Dramatic Metabolic Response to Dual <scp>ICI</scp> With Chemotherapy in Low PD‐<scp>L1 NSCLC</scp> Case
Despite low PD-L1 (Programmed Death-ligand 1) expression, this patient exhibited a dramatic positron emission tomography-computed tomography response to dual immune checkpoint inhibitors with chemotherapy. This case highlights the potential benefits of combination therapy beyond traditional PD-L1-based treatment selection.
Authors
- Shigeto Kondou
- Hidetoshi Itani (ORCID: https://orcid.org/0009-0006-2007-4666)
- Akina Nigi (ORCID: https://orcid.org/0000-0001-9167-5836)
- Keisuke S. Iwamoto (ORCID: https://orcid.org/0000-0002-9290-4677)
- Toshikazu Kumasa
Institutions
- Ise Red Cross Hospital (JP)
Publication Details
- Journal
- Respirology Case Reports
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/rcr2.70150
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05